Technology
Health
Biotechnology
REGENXBIO
$50.689876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$50.68
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$1.55 (3.15%) As of 12:52 PM EDT today
+$1.55 (3.15%) Today
Why Robinhood?
You can buy or sell REGENXBIO and other stocks, options, ETFs, and crypto commission-free!
About RGNX
REGENXBIO Inc. Common Stock, also called REGENXBIO, is a biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. Read More The company was founded by Kennth T. Mills and James M. Wilson on July 16, 2008 and is headquartered in Rockville, MD.
Employees
192
Headquarters
Rockville, Maryland
Founded
2008
Market Cap
1.80B
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
467.62K
High Today
$51.00
Low Today
$49.04
Open Price
$49.51
Volume
208.70K
52 Week High
$83.45
52 Week Low
$38.56
Collections
Technology
Health
Biotechnology
Therapy
2015 IPO
US
North America
Price Paid on Robinhood
2% Higher
Right Now
52 Week Low
$38.56
Average Price Paid
$49.48
52 Week High
$83.45
RGNX Earnings
-$0.89
$0.42
$1.73
$3.04
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Expected Aug 7, After Hours